Autopsy report · NCT02487849

HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian Carcinoma

“actually limited personnel ressources”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Krankenhaus Barmherzige Schwestern Linz

Sponsor type

University, hospital or other

Conditions

Epithelial Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer

Interventions

HIPEC; Carboplatin

Participants

0

Sites

1

Countries

Austria

Trials that died the same way

• The Effect of Ketamine in the Prevention of Hypoventilation in Patients Undergoing Deep Sedation Using Propofol and Fentanyl
  “Change in personnel” (60% match in meaning)
• Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study)
  “Recruitment difficulities” (59% match in meaning)
• Effect of Oral Appliance Therapy on Atrial Fibrillation
  “Recruitment difficulties.” (59% match in meaning)
• Intranasal Oxytocin and Learning in Autism
  “Low recruitment” (57% match in meaning)
• TPF Machine Learning Algorithms
  “Not enough capacity for recruitment” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.